Legelata advises KRKA doo for structuring and obtaining permits for clinical trials of newly developed phase 2 products by KRKA doo for treatment of cardiovascular deaseses within the Republic of Armenia. Should the trials be successful, it will greatly impact the way the healthcare and pharmaceutical industry is treating cardiovascular deaseses and will result in improving the quality of life for millions of people around the world.
Legelata’s team was led by partner Gor Margaryan and associate Karen Chichoyan for delivering such legal advice.
Date: March 2024
